股份回购
Search documents
中国中冶:公司高度重视中小股东利益
Zheng Quan Ri Bao Zhi Sheng· 2025-12-19 15:48
(编辑 袁冠琳) 证券日报网讯 12月19日,中国中冶在互动平台回答投资者提问时表示,中国中冶高度重视中小股东利 益,切实维护股东权益,有效增强投资者信心,进一步稳定及提升公司价值,公司于2025年12月18日公 告以集中竞价方式回购部分A股和H股股份。其中,A股回购金额不低于人民币10亿元且不超过人民币 20亿元,H股回购股份数量不超过有关授予H股回购授权的议案于相关股东会上审议批准当日已发行H 股总数的10%,回购金额不超过人民币5亿元。相关回购方案尚需公司股东会批准后实施。除上述已公 告股份回购计划之外,公司将结合2025年3月29日公告的估值提升计划,通过持续提升经营效率和盈利 能力、持续稳定提供现金分红、加强投资者互动交流、推动公司价值传递、进一步优化产业布局等多种 举措,持续提高公司发展质量,提升公司投资价值。 ...
北京人力:股份回购是上市公司进行市值管理的重要举措之一
Zheng Quan Ri Bao Wang· 2025-12-19 15:13
证券日报网讯12月19日,北京人力(600861)在互动平台回答投资者提问时表示,股份回购是上市公司 进行市值管理的重要举措之一。若有关事项达到披露标准,公司将严格按照监管要求及时履行信息披露 义务。 ...
碧桂园服务(06098.HK)连续5日回购,累计回购1539.70万股
Zheng Quan Shi Bao Wang· 2025-12-19 14:47
证券时报·数据宝统计,碧桂园服务在港交所公告显示,12月19日以每股6.250港元至6.290港元的价格回 购100.00万股,回购金额达625.95万港元。该股当日收盘价6.230港元,下跌1.89%,全天成交额4660.68 万港元。 自12月15日以来公司已连续5日进行回购,合计回购1539.70万股,累计回购金额9680.57万港元。 其间 该股累计下跌2.20%。 | 日期 | 回购股数(万股) | 回购最高价(港元) | 回购最低价(港元) | 回购金额(万港元) | | --- | --- | --- | --- | --- | | 2025.12.19 | 100.00 | 6.290 | 6.250 | 625.95 | | 2025.12.18 | 270.00 | 6.350 | 6.330 | 1713.60 | | 2025.12.17 | 369.70 | 6.330 | 6.220 | 2317.48 | | 2025.12.16 | 500.00 | 6.290 | 6.210 | 3127.38 | | 2025.12.15 | 300.00 | 6.340 | 6.290 ...
小米集团-W(01810.HK)12月19日回购1.52亿港元,已连续2日回购
Zheng Quan Shi Bao Wang· 2025-12-19 14:44
证券时报·数据宝统计,小米集团-W在港交所公告显示,12月19日以每股40.420港元至40.560港元的价 格回购375.00万股,回购金额达1.52亿港元。该股当日收盘价40.540港元,上涨0.85%,全天成交额 43.85亿港元。 | 2025.10.16 | 400.00 | 48.400 | 47.600 | 19184.63 | | --- | --- | --- | --- | --- | | 2025.10.15 | 200.00 | 49.540 | 49.420 | 9895.89 | | 2025.10.14 | 400.00 | 49.000 | 48.440 | 19489.20 | | 2025.10.13 | 400.00 | 50.550 | 47.820 | 19707.82 | | 2025.10.10 | 192.00 | 52.350 | 51.950 | 10003.23 | | 2025.10.08 | 15.00 | 53.250 | 53.050 | 797.60 | | 2025.09.30 | 1.80 | 53.250 | 53.250 | 95.85 ...
中远海控(01919.HK)连续36日回购,累计斥资14.37亿港元
Zheng Quan Shi Bao Wang· 2025-12-19 14:44
今年以来该股累计进行130次回购,合计回购5.00亿股,累计回购金额66.68亿港元。(数据宝) 中远海控回购明细 证券时报·数据宝统计,中远海控在港交所公告显示,12月19日以每股13.470港元至13.730港元的价格回 购396.55万股,回购金额达5366.89万港元。该股当日收盘价13.530港元,下跌1.17%,全天成交额3.23 亿港元。 自10月31日以来公司已连续36日进行回购,合计回购1.05亿股,累计回购金额14.37亿港元。 其间该股 累计上涨1.12%。 | 2025.11.11 | 300.00 | 14.390 | 14.110 | 4254.13 | | --- | --- | --- | --- | --- | | 2025.11.10 | 300.00 | 14.350 | 14.100 | 4256.26 | | 2025.11.07 | 140.80 | 14.230 | 13.800 | 1985.89 | | 2025.11.06 | 153.00 | 13.840 | 13.570 | 2098.69 | | 2025.11.05 | 125.00 | 13.59 ...
海正药业:发布回购股份方案是基于对公司未来持续稳定发展的信心和对公司价值的高度认可
Zheng Quan Ri Bao Wang· 2025-12-19 11:43
证券日报网讯12月19日,海正药业(600267)在互动平台回答投资者提问时表示,公司发布回购股份方 案是基于对公司未来持续稳定发展的信心和对公司价值的高度认可,后续将根据回购方案及市场情况在 回购期限内择机实施回购,并及时履行信息披露义务。 ...
盐津铺子:拟2.84亿 - 3.28亿元回购股份用于股权激励
Xin Lang Cai Jing· 2025-12-19 10:50
Core Viewpoint - The company plans to repurchase a portion of its A-shares through centralized bidding, with a price not exceeding 109.32 yuan per share, aiming to enhance shareholder value and support its equity incentive plan [1] Group 1: Repurchase Details - The repurchase will involve a quantity of no less than 2.6 million shares and no more than 3 million shares, representing approximately 0.95% to 1.10% of the total share capital [1] - The estimated amount for the repurchase is between 284 million and 328 million yuan, funded by self-owned or self-raised capital [1] - The repurchase period is set to not exceed 6 months and has already been approved by the board of directors, eliminating the need for shareholder meeting deliberation [1] Group 2: Management and Shareholder Plans - As of the announcement date, the company's directors, senior management, and controlling shareholders have no plans to reduce their holdings during the repurchase period [1] - A dedicated account for the repurchase has been established by the company [1]
证券代码:600211 证券简称:西藏药业 公告编号:2025-044
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-12-19 10:21
Core Viewpoint - The company plans to repurchase shares with a total amount between RMB 170 million and RMB 200 million to implement an employee stock ownership plan and enhance long-term incentive mechanisms [2][3][8]. Group 1: Repurchase Plan Details - The repurchase will be funded by the company's own funds [3][14]. - The maximum repurchase price is set at RMB 55 per share, which is 150% of the average trading price over the last 30 trading days prior to the board's decision [3][13]. - The repurchase will be conducted through centralized bidding on the Shanghai Stock Exchange [4][9]. Group 2: Implementation Timeline and Conditions - The repurchase period will not exceed 12 months from the board's approval date [4][9]. - The repurchase may be completed earlier if the maximum funding limit is reached or if the board decides to terminate the plan [10]. Group 3: Shareholder and Management Plans - There are no plans for share reduction by directors, senior management, or major shareholders in the next three to six months [4][16]. - The company assures that there are no conflicts of interest or insider trading related to the repurchase plan [16]. Group 4: Financial Impact and Future Plans - As of September 30, 2025, the company's total assets are RMB 5.816 billion, with net assets of RMB 3.551 billion [15]. - The repurchase funds, at the upper limit of RMB 200 million, would represent 3.44% of total assets and 5.63% of net assets, indicating a manageable impact on the company's financials [15]. - The repurchased shares are intended for employee stock ownership plans, which are expected to enhance employee motivation and align interests between shareholders and employees [8][15].
信利国际12月19日斥资108万港元回购100万股
Zhi Tong Cai Jing· 2025-12-19 09:23
Group 1 - The company, Xinyi International (00732), announced a share buyback plan [1] - The total expenditure for the buyback is HKD 1.08 million [1] - The company will repurchase 1 million shares at a price of HKD 1.08 per share [1]
三诺生物:截至2025年11月30日公司已累计回购股份931.98万股
Zheng Quan Ri Bao Wang· 2025-12-19 08:17
证券日报网讯12月18日,三诺生物(300298)在互动平台回答投资者提问时表示,截至2025年11月30 日,公司已累计回购股份931.98万股,占总股本的1.66%,已投入回购资金超1.84亿元,体现了公司对 公司长期投资价值的坚定认同。 ...